Our in vitro effects propose that EAM-2201 should be examined with regard to opportunity in vivo pharmacokinetic drug–drug interactions due to time-dependent inhibition of CYP2C8, CYP2C9, CYP2C19 and CYP3A4 actions and competitive inhibition of UGT1A3 exercise. This is the preview of membership written content, log in via an establishment to https://keithb959lao2.vblogetin.com/profile